Loading…

Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2019-02, Vol.94 (2), p.E50-E53
Main Authors:	Klener, Pavel, Salek, David, Pytlik, Robert, Mocikova, Heidi, Forsterova, Kristina, Blahovcova, Petra, Campr, Vit, Prochazka, Vit, Obr, Ales, Jaksa, Radek, Kuntscherova, Jana, Boudová, Ludmila, Kodet, Roman, Janikova, Andrea, Trneny, Marek
Format:	Article
Language:	English
Subjects:	Autografts Hematology Immunotherapy Mantle cell lymphoma Monoclonal antibodies Rituximab Stem cell transplantation Targeted cancer therapy
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!